Non-invasive prenatal testing (NIPT)

Introducing the Generation® screen

  • Simple

    • A single tube of blood drawn from your arm;
  • Convenient

    • You can have blood collected in one of our collection centres from as early as 10 weeks;
  • Accurate6,7,13

    • >99% Accuracy for Trisomy 21, 18 & 13
  • Australian

    • Your test is performed in Australia
  • Reliable

    • It has the lowest test failure rate of any NIPT (0.1%)6;
  • Fast

    • Your healthcare provider will receive results within 3-7 business days from receipt in our laboratory.
  • Extended Services

    • Exclusively able to be bundled with other advanced scientific services such as cord blood stem cell banking for your baby at birth

What is the Generation® non-invasive prenatal test?

How does the Generation® test work?

Is the Generation® test right for me?

What kind of conditions can the Generation® test detect?

Why should I choose the Generation® test over others?

How will my test be reported?

Do normal Generation® test results mean that my baby will be perfectly healthy?

How do I know I can trust the Generation® test?

How do I organise to have the Generation® test?

Does Medicare or private health insurance cover the cost of the Generation® prenatal test?

Next Steps

Contact Us

Call us on
1800 822 999
or email us at
info@generationNIPT.com.au

Get Info Pack

Request our comprehensive information pack to discover everything you need to know

References

1. Bhatt S, Parsa S, Snyder H, et al. Clinical Laboratory Experience with Noninvasive Prenatal Testing: Update on Clincially Relevant Metrics. ISPD 2014 poster.
2. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890-901.
3. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in non-invasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn. 2013;33:569-574.
4. Bianchi DW, Parker RL, Wentworth J et al. DNA Sequencing versus Standard Prenatal Aneuploidy Screening. N Engl J Med 2014; 370:799-808.
5. Verinata Health, Inc. (2012) Analytical Validation of the verifi Prenatal Test: Enhanced Test Performance For Detecting Trisomies 21, 18 and 13 and the Option for Classification of Sex Chromosome Status. Redwood City, CA.